US Patent Issued to Amgen on June 9 for "TREM2 antigen binding proteins and uses thereof" (California Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,788, issued on June 9, was assigned to Amgen Inc. (Thousand Oaks, Calif.).

"TREM2 antigen binding proteins and uses thereof" was invented by Ian N. Foltz (Thousand Oaks, Calif.), Shilpa Sambashivan (Thousand Oaks, Calif.), Irwin Chen (Thousand Oaks, Calif.), Susie Miki Harris (Thousand Oaks, Calif.), Dora Toledo Warshaviak (Thousand Oaks, Calif.), Ian Driver (Thousand Oaks, Calif.) and Daniel Lu (Thousand Oaks, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to antigen binding proteins, such as monoclonal antibodies, that specifically bind to and activate human triggering receptor expressed on myeloid cells-2 (TREM...